By: Maribel Yoo On: February 10, 2017 In: Nexus Strategy, Portfolio Comments: 0

eNeura ( is an electroceutical company that has developed a portable, non-invasive transcranial magnetic stimulation device for treatment of migraine.

The eNeura SAVI TMS device is currently the only non-drug therapy clinically proven to effectively prevent, reduce, or stop pain associated with migraine with aura, and it does so with no unwanted or serious side effects. The device has received FDA and CE Mark approval, and is available by prescription in the United States and European Union.

Deal Source

Dr. Robert Fischell

Board Representation

R. Jacob Vogelstein

George Petrocheilos